Therapeutic use of PI3K/Akt inhibitors has been applied in patients with differenttypes of cancer,29 whereas GSK3β protein inhibitors are used in the treatment ofneurodegenerative diseases such as Alzheimer’s disease.30 The gene discussed is AKT1; the disease is Alzheimer disease.